Muhammad A. Rayhan, Mudatsir Mudatsir, Nurjannah Nurjannah, Ichsan Ichsan, Ichsan Ichsan, Mehrdad Amir-Behghadami, Yousef S. Khader, Ai Koyanagi, Ranjit Sah, Sandro G. Viveiros-Rosa, Mohammed A. Mamun, Mohammed A. Mamun, Yohannes K. Lemu, Assarag Bouchra, Laure S. G. Linguissi, Aamer Ikram, Dina E. Sallam, Konstantinos Parperis, Uwe Wollina, Marius Rademaker, Sandro Vento, Said Usman
Vaccines are urgently needed to control the Coronavirus disease 2019 (COVID-19) pandemic. The aim of this study was to determine the acceptance of and willingness to purchase a hypothetical COVID-19 vaccine in the general population of Aceh, a holistic Shariah law implementation province in Indonesia. An online cross-sectional study was conducted using a quota sampling technique between 1 to 24 September 2021. To determine hypothetical vaccine acceptance, respondents were asked if they were willing to accept vaccines with combinations of either 50% or 95% effectiveness and either 5% or 20% risk of adverse effects. Willingness to purchase was assessed by asking whether the participants would pay for such vaccines at certain price points. Logistic regression analysis was used to assess the associated determinants. Out of 377 respondents included in the final analysis, 86.5% were willing to accept a COVID-19 vaccine with 95% effectiveness and 5% adverse effects. The acceptance rate dropped to 45.1% if the risk of adverse effects was 20%. Vaccines with 50% effectiveness and 5% adverse effects were acceptable to 42.2% but the acceptance went down to 17.2% if the risk of adverse effects increased to 20%. Multivariate analysis found that men were twice as likely to accept a vaccine with 95% effectiveness and 5% adverse effects compared to females (aOR: 2.01; 95% CI 1.05-3.86). We found that 156/377 (41.3%) of respondents were willing to purchase a COVID-19 vaccine and of these participants 71.1% were willing to pay between © 2022, School of Medicine, Universitas Syiah Kuala. All rights reserved.
School of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia; Department of Microbiology, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia; Department of Public Health, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia; Tsunami and Disaster Mitigation Research Center (TDMR), Universitas Syiah Kuala, Banda Aceh, Indonesia; Iranian Center of Excellence in Health Management, Department of Health Service Management, School of Management and Medical Informatics, Tabriz University of Medical Sciences, Tabriz, Iran; Jordan University of Science and Technology, Irbid, Jordan; Research and Development Unit, Parc Sanitari Sant Joan de Déu, ICREA, CIBERSAM, ISCIII, Barcelona, Spain; Tribhuvan University Teaching Hospita, Institute of Medicine, Kathmandu, Nepal; Pharmacy Division, Instituto Nacional da Propriedade Industrial, Rio de Janeiro, Rio de Janeiro, Brazil; Department of Public Health and Informatics, Jahangirnagar University, Dhaka, Bangladesh; CHINTA Research Bangladesh, Dhaka, Bangladesh; Department of Health, Behavior and Society, Faculty of Public Health, Jimma University, Ethiopia; National School of Public Health, Rabat, Morocco; Institut National de Recherche en Science de la Santé, Brazzaville, Democratic Republic Congo; National Institutes of Health, Islamabad, Pakistan; Pediatrics and Pediatric Nephrology, Faculty of Medicine, Ain Shams University, Cairo, Egypt; Department of Internal Medicin, University of Cyprus Medical School, Nicosia, Cyprus; Department of Dermatology and Allergology, Städtisches Klinikum Dresden, Academic Teaching Hospital, Dresden, Germany; Clinical Trials New Zealand, Hamilton, New Zealand; Faculty of Medicine, University of Puthisastra, Phnom Penh, Cambodia
Research at a Glance
Register to unlock
Topics & SDG Alignment
Register to unlock
Collaboration
Register to unlock
Author Profile (Selected)
Register to unlock
References Overview
Register to unlock
Journal & Source
Register to unlock
Metadata & Integrity
Register to unlock